|Bid||36.00 x 800|
|Ask||36.30 x 800|
|Day's range||36.22 - 37.03|
|52-week range||30.59 - 48.50|
|Beta (5Y monthly)||1.15|
|PE ratio (TTM)||N/A|
|Earnings date||03 Nov 2021 - 08 Nov 2021|
|Forward dividend & yield||N/A (N/A)|
|1y target est||54.38|
LEWISVILLE, Texas, September 29, 2021--Orthofix Medical Inc. (NASDAQ:OFIX), a global medical device company with a spine and orthopedics focus, today provided a business update. The Company has experienced the impact of higher than expected volumes of deferred or rescheduled elective procedures resulting from hospital procedural restrictions, both in the U.S. and internationally, associated with the recent surge in COVID-19 Delta variant cases. As a result, the Company expects revenue growth for
Orthofix (OFIX) reveals that more than 60,000 M6-C artificial cervical discs have been implanted worldwide.
LEWISVILLE, Texas, September 27, 2021--Orthofix announces that more than 60,000 M6-C artificial cervical discs have been implanted worldwide as an alternative to cervical fusion.